These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28441265)

  • 21. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.
    Wang T; Liu G; Lin H
    PLoS One; 2020; 15(8):e0237321. PubMed ID: 32853226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T; Inoue Y; Takeuchi K; Okada Y; Tamura K; Tomomasa T; Kobayashi T; Morikawa A
    Circulation; 2006 Jun; 113(22):2606-12. PubMed ID: 16735679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study.
    Yan Y; Qiao L; Hua Y; Shao S; Zhang N; Wu M; Liu L; Zhou K; Liu X; Wang C
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):147. PubMed ID: 34563210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological involvement in Kawasaki disease: a retrospective study.
    Liu X; Zhou K; Hua Y; Wu M; Liu L; Shao S; Wang C
    Pediatr Rheumatol Online J; 2020 Jul; 18(1):61. PubMed ID: 32664982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan.
    Kuwabara M; Yashiro M; Ae R; Yanagawa H; Nakamura Y
    Int J Cardiol; 2018 Oct; 269():334-338. PubMed ID: 30049499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
    Huang H; Jiang J; Shi X; Qin J; Dong J; Xu L; Huang C; Liu Y; Zheng Y; Hou M; Shen Q; Zeng B; Qian G; Yang F; Lv H
    Ann Med; 2022 Dec; 54(1):442-453. PubMed ID: 35099338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low risk of treatment resistance in Down syndrome with Kawasaki disease.
    Takatsuki S; Ogata S; Ishii M; Yokozawa M; Ono M; Fujiwara M; Ida H; Motomura H; Moriuchi H; Taketazu M; Kawamura Y; Kawano T; Izumi T; Shiono J; Tsuchiya S; Tsuchiya K; Goushi T; Ichida F; Saji T
    Pediatr Int; 2017 Dec; 59(12):1236-1239. PubMed ID: 28960680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
    J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Significance of QT Interval Dispersion in the Response to Intravenous Immunoglobulin Therapy in Kawasaki Disease.
    Motoki N; Akazawa Y; Yamazaki S; Hachiya A; Motoki H; Matsuzaki S; Koike K
    Circ J; 2017 Mar; 81(4):537-542. PubMed ID: 28154289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease.
    Fu PP; Du ZD; Pan YS
    Pediatr Infect Dis J; 2013 Aug; 32(8):e319-23. PubMed ID: 23446442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease.
    Kobayashi T; Inoue Y; Otani T; Morikawa A; Kobayashi T; Takeuchi K; Saji T; Sonobe T; Ogawa S; Miura M; Arakawa H
    Pediatr Infect Dis J; 2009 Jun; 28(6):498-502. PubMed ID: 19504733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS; Lee J; Jang GY; Lee J; Lee KC; Son CS; Lee JW
    Am J Cardiol; 2015 Jul; 116(2):301-6. PubMed ID: 25975725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.